bokomslag Myeloid-Derived Suppressor Cells and Cancer
Kropp & själ

Myeloid-Derived Suppressor Cells and Cancer

David Escors James E Talmadge Karine Breckpot Jo A Van Ginderachter Grazyna Kochan

Pocket

769:-

Funktionen begränsas av dina webbläsarinställningar (t.ex. privat läge).

Uppskattad leveranstid 7-11 arbetsdagar

Fri frakt för medlemmar vid köp för minst 249:-

  • 102 sidor
  • 2016
The book starts with an introduction to and history of myeloid-derived suppressor cells (MDSCs), followed by a description of their differentiation, their role in the tumour microenvironment and their therapeutic targeting. It closes with an outlook on future developments. In cancer patients, myelopoiesis is perturbed and instead of generating immunogenic myeloid cells (such as dendritic cells, inflammatory macrophages and granulocytes), there is an increase in highly immature MDSCs. These cells are distributed systemically, resulting in general immunosuppression. They also infiltrate tumours, promoting their progression and metastasis by inhibiting the natural anti-tumour immune response. As these cells also interact with classical anti-neoplastic treatments, they have become major therapeutic targets in the pharmaceutical industry and in oncology research.
  • Författare: David Escors, James E Talmadge, Karine Breckpot, Jo A Van Ginderachter, Grazyna Kochan
  • Illustratör: Bibliographie
  • Format: Pocket/Paperback
  • ISBN: 9783319268194
  • Språk: Engelska
  • Antal sidor: 102
  • Utgivningsdatum: 2016-03-23
  • Förlag: Springer International Publishing AG